We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





POC Reader Automatically Analyzes COVID-19 Test Strips and Transmits Results Electronically

By LabMedica International staff writers
Posted on 11 Dec 2020
A battery-powered reader automatically quantifies and analyzes COVID-19 test strips and then transmits the test results electronically to doctors, hospitals, and state and federal agencies.

GattaCo (Murrieta CA, USA) and iAssay (San Diego, CA, USA) have entered into a partnership to integrate and optimize their products in an effort to provide enhanced rapid serology testing, including COVID-19 antibody testing and electronic test result transmission to federal and state agencies via the cloud at the point of care.

GattaCo has developed and patented rapid and automatic plasma separation tools, called the A-PON and pediatric-focused mini-PON Kits. More...
The PON Kits (PON referring to plasma at the point of need) separate antibody-rich plasma from whole blood collected from a finger-stick without the need for a centrifuge or venous blood-draw. The plasma generated by the PON Kits can transform a normally Yes or No antibody test to a semi-quantitative test and enable more sensitive quantitative detection by the iAssay CyberReader device, reducing false positives and negatives.

iAssay’s CyberReader automatically quantifies and analyzes COVID-19 test strips, then transmits the test results electronically to doctors, hospitals, and state and federal agencies. When used as directed, PON derived plasma can be obtained in under three minutes, in any setting, including at a doctor’s office, at home, at screening centers, or anywhere finger-stick blood can be collected. The A-PON and mini-PON Kits require no power, support equipment or skill on the part of the user, eliminating the need for the phlebotomist, lab tech and centrifuge infrastructure that is otherwise required to obtain plasma. The battery-powered iAssay CyberReader provides a quick and portable method for analyzing strips incubated with PON produced plasma and storing test results in the Cloud.

“Helping to alleviate the COVID-19 testing bottleneck with improved test accuracy, eliminating the need for centrifugation of blood samples and reducing clinical lab restrictions will improve patient care and at the same time, provide public health agencies and other vested parties relevant data to support informed decision making and improved management of the COVID-19 crisis,” said Dr. Michael McNeely, President and CEO of GattaCo.

“It’s a natural fit for both companies,” said Lonnie Adelman, CEO & Founder at iAssay. “iAssay provides a sensitive and accurate Reader device and Cloud connectivity, and GattaCo provides the microfluidics that optimize the strip chemical reactions. Together, we are working on improving the full system performance by using our combined strengths in engineering and biotechnological medical device design.”

Related Links:
iAssay
GattaCo



Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.